Literature DB >> 27393126

Preventing Scars after Injury with Partial Irreversible Electroporation.

Alexander Golberg1, Martin Villiger2, Saiqa Khan3, Kyle P Quinn4, William C Y Lo5, Brett E Bouma5, Martin C Mihm6, William G Austen3, Martin L Yarmush7.   

Abstract

Preventing the formation of hypertrophic scars, especially those that are a result of major trauma or burns, would have enormous impact in the fields of regenerative and trauma medicine. In this report, we introduce a noninvasive method to prevent scarring based on nonthermal partial irreversible electroporation. Contact burn injuries in rats were treated with varying treatment parameters to optimize the treatment protocol. Scar surface area and structural properties of the scar were assessed with histology and non-invasive, longitudinal imaging with polarization-sensitive optical coherence tomography. We found that partial irreversible electroporation using 200 pulses of 250 V and 70 μs duration, delivered at 3 Hz every 20 days during a total of five therapy sessions after the initial burn injury, resulted in a 57.9% reduction of the scar area compared with untreated scars and structural features approaching those of normal skin. Unlike humans, rats do not develop hypertrophic scars. Therefore, the use of a rat animal model is the limiting factor of this work.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27393126      PMCID: PMC5516938          DOI: 10.1016/j.jid.2016.06.620

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  40 in total

Review 1.  Emerging Therapies for Scar Prevention.

Authors:  Lisa Block; Ankush Gosain; Timothy W King
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-10-01       Impact factor: 4.730

Review 2.  Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management.

Authors:  Bolaji O Mofikoya; Wasiu L Adeyemo; Abbas A Abdus-salam
Journal:  Nig Q J Hosp Med       Date:  2007 Oct-Dec

Review 3.  The Taguchi methodology as a statistical tool for biotechnological applications: a critical appraisal.

Authors:  Ravella Sreenivas Rao; C Ganesh Kumar; R Shetty Prakasham; Phil J Hobbs
Journal:  Biotechnol J       Date:  2008-04       Impact factor: 4.677

4.  Current Laser Resurfacing Technologies: A Review that Delves Beneath the Surface.

Authors:  Jason Preissig; Kristy Hamilton; Ramsey Markus
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

5.  Irreversible electroporation for treatment of liver cancer.

Authors:  Govindarajan Narayanan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

6.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

7.  Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open-label controlled clinical and histopathological study.

Authors:  Bakr M El-Zawahry; Rehab M Sobhi; Dalia A Bassiouny; Sahar A Tabak
Journal:  J Cosmet Dermatol       Date:  2015-08-11       Impact factor: 2.696

8.  Longitudinal, 3D Imaging of Collagen Remodeling in Murine Hypertrophic Scars In Vivo Using Polarization-Sensitive Optical Frequency Domain Imaging.

Authors:  William C Y Lo; Martin Villiger; Alexander Golberg; G Felix Broelsch; Saiqa Khan; Christine G Lian; William G Austen; Martin Yarmush; Brett E Bouma
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

9.  Intralesional cryosurgery for the treatment of hypertrophic scars and keloids following aesthetic surgery: the results of a prospective observational study.

Authors:  Yaron Har-Shai; Wifred Brown; Daniel Labbé; Anne Dompmartin; Irina Goldine; Tamir Gil; Issa Mettanes; Norbert Pallua
Journal:  Int J Low Extrem Wounds       Date:  2008-09       Impact factor: 2.057

Review 10.  Update on hypertrophic scar treatment.

Authors:  Felipe Bettini Rabello; Cleyton Dias Souza; Jayme Adriano Farina Júnior
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

View more
  6 in total

Review 1.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

2.  Skin regeneration with all accessory organs following ablation with irreversible electroporation.

Authors:  Alexander Golberg; Martin Villiger; G Felix Broelsch; Kyle P Quinn; Hassan Albadawi; Saiqa Khan; Michael T Watkins; Irene Georgakoudi; William G Austen; Marianna Bei; Brett E Bouma; Martin C Mihm; Martin L Yarmush
Journal:  J Tissue Eng Regen Med       Date:  2017-05-23       Impact factor: 3.963

3.  Selective Inactivation of Pseudomonas aeruginosa and Staphylococcus epidermidis with Pulsed Electric Fields and Antibiotics.

Authors:  Andrey Ethan Rubin; Osman Berk Usta; Rene Schloss; Martin Yarmush; Alexander Golberg
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-03       Impact factor: 4.730

4.  Measuring collagen injury depth for burn severity determination using polarization sensitive optical coherence tomography.

Authors:  Taylor M Cannon; Néstor Uribe-Patarroyo; Martin Villiger; Brett E Bouma
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

5.  High-Voltage, Pulsed Electric Fields Eliminate Pseudomonas aeruginosa Stable Infection in a Mouse Burn Model.

Authors:  Mengjie Wu; Andrey Ethan Rubin; Tianhong Dai; Rene Schloss; Osman Berk Usta; Alexander Golberg; Martin Yarmush
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-12-18       Impact factor: 4.947

6.  Prediction of Scar Size in Rats Six Months after Burns Based on Early Post-injury Polarization-Sensitive Optical Frequency Domain Imaging.

Authors:  Eli Kravez; Martin Villiger; Brett Bouma; Martin Yarmush; Zohar Yakhini; Alexander Golberg
Journal:  Front Physiol       Date:  2017-12-01       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.